Park KD - Search Results

1

Rational design of an indolebutanoic acid derivative as a novel aldose reductase inhibitor based on docking and 3D QSAR studies of phenethylamine derivatives.

Sun WS, Park YS, Yoo J, Park KD, Kim SH, Kim JH, Park HJ. Sun WS, et al. Among authors: park ys, park kd, park hj. J Med Chem. 2003 Dec 18;46(26):5619-27. doi: 10.1021/jm0205346. J Med Chem. 2003. PMID: 14667216

2

Antimicrobial activity of 3-O-acyl-(-)-epicatechin and 3-O-acyl-(+)-catechin derivatives.

Park KD, Park YS, Cho SJ, Sun WS, Kim SH, Jung DH, Kim JH. Park KD, et al. Among authors: park ys. Planta Med. 2004 Mar;70(3):272-6. doi: 10.1055/s-2004-818923. Planta Med. 2004. PMID: 15114510

3

Anticancer activity of 3-O-acyl and alkyl-(-)-epicatechin derivatives.

Park KD, Lee SG, Kim SU, Kim SH, Sun WS, Cho SJ, Jeong DH. Park KD, et al. Bioorg Med Chem Lett. 2004 Oct 18;14(20):5189-92. doi: 10.1016/j.bmcl.2004.07.063. Bioorg Med Chem Lett. 2004. PMID: 15380225

4

N-Benzylbenzamides: a new class of potent tyrosinase inhibitors.

Cho SJ, Roh JS, Sun WS, Kim SH, Park KD. Cho SJ, et al. Among authors: park kd. Bioorg Med Chem Lett. 2006 May 15;16(10):2682-4. doi: 10.1016/j.bmcl.2006.02.018. Epub 2006 Mar 2. Bioorg Med Chem Lett. 2006. PMID: 16513349

5

Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents.

Park KD, Lee JH, Kim SH, Kang TH, Moon JS, Kim SU. Park KD, et al. Bioorg Med Chem Lett. 2006 Aug 1;16(15):3913-6. doi: 10.1016/j.bmcl.2006.05.033. Epub 2006 May 30. Bioorg Med Chem Lett. 2006. PMID: 16730982

6

Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.

Song JM, Park KD, Lee KH, Byun YH, Park JH, Kim SH, Kim JH, Seong BL. Song JM, et al. Among authors: park jh, park kd. Antiviral Res. 2007 Nov;76(2):178-85. doi: 10.1016/j.antiviral.2007.07.001. Epub 2007 Aug 1. Antiviral Res. 2007. PMID: 17709148

7

Synthesis and antifungal activity of a novel series of 13-(4-isopropylbenzyl)berberine derivatives.

Park KD, Cho SJ, Moon JS, Kim SU. Park KD, et al. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6551-4. doi: 10.1016/j.bmcl.2010.09.045. Epub 2010 Sep 21. Bioorg Med Chem Lett. 2010. PMID: 20932752

8

Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson's disease.

Park HR, Kim J, Kim T, Jo S, Yeom M, Moon B, Choo IH, Lee J, Lim EJ, Park KD, Min SJ, Nam G, Keum G, Lee CJ, Choo H. Park HR, et al. Among authors: park kd. Bioorg Med Chem. 2013 Sep 1;21(17):5480-7. doi: 10.1016/j.bmc.2013.05.066. Epub 2013 Jun 11. Bioorg Med Chem. 2013. PMID: 23810676

9

Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.

Choi JW, Jang BK, Cho NC, Park JH, Yeon SK, Ju EJ, Lee YS, Han G, Pae AN, Kim DJ, Park KD. Choi JW, et al. Among authors: park jh, park kd. Bioorg Med Chem. 2015 Oct 1;23(19):6486-96. doi: 10.1016/j.bmc.2015.08.012. Epub 2015 Aug 19. Bioorg Med Chem. 2015. PMID: 26337020

10

Synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as mGluR5 (metabotropic glutamate receptor 5) antagonists.

Vu HN, Kim JY, Hassan AH, Choi K, Park JH, Park KD, Lee JK, Pae AN, Choo H, Min SJ, Cho YS. Vu HN, et al. Among authors: park jh, park kd. Bioorg Med Chem Lett. 2016 Jan 1;26(1):140-4. doi: 10.1016/j.bmcl.2015.11.012. Epub 2015 Nov 5. Bioorg Med Chem Lett. 2016. PMID: 26598462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

680 results

Search Page